Repository logo
 

Multiple pathways of escape from HIV broadly cross-neutralizing V2-dependent antibodies.

Simple item page
dc.contributor.authorMoore, Penelope L.
dc.contributor.authorSheward, Daniel J.
dc.contributor.authorNonyane, Molati.
dc.contributor.authorRanchobe, Nthabeleng.
dc.contributor.authorHermanus, Tandile.
dc.contributor.authorGray, Elin Solomonovna.
dc.contributor.authorAbdool Karim, Salim Safurdeen.
dc.contributor.authorWilliamson, Carolyn.
dc.contributor.authorMorris, Lynn.
dc.date.accessioned2013-11-18T06:27:04Z
dc.date.available2013-11-18T06:27:04Z
dc.date.created2012
dc.date.issued2012
dc.description.abstractBroadly cross-neutralizing (BCN) antibodies are likely to be critical for an effective HIV vaccine. However, the ontogeny of such antibodies and their relationship with autologous viral evolution is unclear. Here, we characterized viral evolution in CAP256, a subtype C-infected individual who developed potent BCN antibodies targeting positions R166 and K169 in the V2 region. CAP256 was superinfected at 3 months postinfection with a virus that was highly sensitive to BCN V2-dependent monoclonal antibodies. The autologous neutralizing response in CAP256 was directed at V1V2, reaching extremely high titers (>1:40,000) against the superinfecting virus at 42 weeks, just 11 weeks prior to the development of the BCN response targeting the same region. Recombination between the primary and superinfecting viruses, especially in V2 and gp41, resulted in two distinct lineages by 4 years postinfection. Although neutralization of some CAP256 clones by plasma from as much as 2 years earlier suggested incomplete viral escape, nonetheless titers against later clones were reduced at least 40-fold to less than 1:1,000. Escape mutations were identified in each lineage, either at R166 or at K169, suggesting that strain-specific and BCN antibodies targeted overlapping epitopes. Furthermore, the early dependence of CAP256 neutralizing antibodies on the N160 glycan decreased with the onset of neutralization breadth, indicating a change in specificity. These data suggest rapid maturation, within 11 weeks, of CAP256 strain-specific antibodies to acquire breadth, with implications for the vaccine elicitation of BCN V2-dependent antibodies. Overall these studies demonstrate that ongoing viral escape is possible, even from BCN antibodies.en
dc.identifier.citationMoore, P.L., et al. 2013. Multiple pathways of escape from HIV broadly cross-neutralizing V2-dependent antibodies. J. Virol. 87(9) pp.4882-4894.en
dc.identifier.issn0022-538X
dc.identifier.urihttp://dx.doi.org/10.1128/JVI.03424-12.en
dc.identifier.urihttp://hdl.handle.net/10413/10020
dc.language.isoenen
dc.publisherAmerican Society for Microbiology.en
dc.subjectAIDS vaccines.en
dc.subjectHIV (Viruses)--Research.en
dc.subjectAntiretroviral agents.en
dc.subjectHIV antibodies.en
dc.subjectHIV infections--Prevention.en
dc.subject.otherNeutralizing antibodies.en
dc.titleMultiple pathways of escape from HIV broadly cross-neutralizing V2-dependent antibodies.en
dc.typePeer reviewed journal articleen

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Moore_Penny_L_2013.pdf
Size:
2.39 MB
Format:
Adobe Portable Document Format
Description:
Peer reviewed journal article
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.64 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Research papers (Caprisa)